ENDOCYTOSIS PATHWAYS FOR NUCLEIC ACID THERAPEUTICS

Overview

Journal Nano Life

Publisher World Scientific

Specialty Biomedical Engineering

Date 2013 Aug 20

PMID 23956796

Citations 4

Authors

Amanda P Malefyt

S Patrick Walton

Christina Chan

Affiliations

Soon will be listed here.

Abstract

The development of nanoscale delivery vehicles for siRNAs is a current topic of considerable importance. However, little is understood about the exact trafficking mechanisms for siRNA-vehicle complexes across the plasma membrane and into the cytoplasm. While some information can be gleaned from studies on delivery of plasmid DNA, the different delivery requirements for these two vehicles makes drawing specific conclusions a challenge. However, using chemical inhibitors of different endocytosis pathways, studies on which endocytotic pathways are advantageous and deleterious for the delivery of nucleic acid drugs are emerging. Using this information as a guide, it is expected that the future development of effective siRNA delivery vehicles and therapeutics will be greatly improved.

Citing Articles

Unveiling the power of mitochondrial transfer in cancer progression: a perspective in ovarian cancer.

Wang C, Xie C J Ovarian Res. 2024; 17(1):233.

PMID: 39580453 PMC: 11585251. DOI: 10.1186/s13048-024-01560-8.

Endocytosis Controls siRNA Efficiency: Implications for siRNA Delivery Vehicle Design and Cell-Specific Targeting.

Vocelle D, Chan C, Walton S Nucleic Acid Ther. 2019; 30(1):22-32.

PMID: 31718426 PMC: 6987736. DOI: 10.1089/nat.2019.0804.

Multicomponent peptide assemblies.

Raymond D, Nilsson B Chem Soc Rev. 2018; 47(10):3659-3720.

PMID: 29697126 PMC: 6538069. DOI: 10.1039/c8cs00115d.

Dextran functionalization enhances nanoparticle-mediated siRNA delivery and silencing.

Vocelle D, Chesniak O, Malefyt A, Comiskey G, Adu-Berchie K, Smith 3rd M Technology (Singap World Sci). 2016; 4(1).

PMID: 27774502 PMC: 5072529. DOI: 10.1142/S2339547816400100.

References

Ivanov A . Exocytosis and endocytosis. Preface. Methods Mol Biol. 2008; 440:v-vi. DOI: 10.1007/978-1-59745-178-9. View

Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y . Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem. 1991; 266(26):17707-12. View

Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood M . Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011; 29(4):341-5. DOI: 10.1038/nbt.1807. View

Hansen S, Sandvig K, van Deurs B . Clathrin and HA2 adaptors: effects of potassium depletion, hypertonic medium, and cytosol acidification. J Cell Biol. 1993; 121(1):61-72. PMC: 2119777. DOI: 10.1083/jcb.121.1.61. View

Gabrielson N, Pack D . Efficient polyethylenimine-mediated gene delivery proceeds via a caveolar pathway in HeLa cells. J Control Release. 2009; 136(1):54-61. DOI: 10.1016/j.jconrel.2009.02.003. View

Whitehead K, Sahay G, Li G, Love K, Alabi C, Ma M . Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery. Mol Ther. 2011; 19(9):1688-94. PMC: 3182356. DOI: 10.1038/mt.2011.141. View

Krieg A . Is RNAi dead?. Mol Ther. 2011; 19(6):1001-2. PMC: 3129789. DOI: 10.1038/mt.2011.94. View

Phonphok Y, Rosenthal K . Stabilization of clathrin coated vesicles by amantadine, tromantadine and other hydrophobic amines. FEBS Lett. 1991; 281(1-2):188-90. DOI: 10.1016/0014-5793(91)80390-o. View

McLendon P, Fichter K, Reineke T . Poly(glycoamidoamine) vehicles promote pDNA uptake through multiple routes and efficient gene expression via caveolae-mediated endocytosis. Mol Pharm. 2010; 7(3):738-50. DOI: 10.1021/mp900282e. View

10.

Reilly M, Larsen J, Sullivan M . Histone H3 tail peptides and poly(ethylenimine) have synergistic effects for gene delivery. Mol Pharm. 2012; 9(5):1031-40. DOI: 10.1021/mp200372s. View

11.

Davidson B, McCray Jr P . Current prospects for RNA interference-based therapies. Nat Rev Genet. 2011; 12(5):329-40. PMC: 7097665. DOI: 10.1038/nrg2968. View

12.

Leuschner P, Ameres S, Kueng S, Martinez J . Cleavage of the siRNA passenger strand during RISC assembly in human cells. EMBO Rep. 2006; 7(3):314-20. PMC: 1456892. DOI: 10.1038/sj.embor.7400637. View

13.

Lamaze C, Schmid S . The emergence of clathrin-independent pinocytic pathways. Curr Opin Cell Biol. 1995; 7(4):573-80. DOI: 10.1016/0955-0674(95)80015-8. View

14.

Damm E, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Helenius A . Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol. 2005; 168(3):477-88. PMC: 2171728. DOI: 10.1083/jcb.200407113. View

15.

Burke R, Pun S . Extracellular barriers to in Vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Bioconjug Chem. 2008; 19(3):693-704. DOI: 10.1021/bc700388u. View

16.

Carthew R, Sontheimer E . Origins and Mechanisms of miRNAs and siRNAs. Cell. 2009; 136(4):642-55. PMC: 2675692. DOI: 10.1016/j.cell.2009.01.035. View

17.

Cho Y, Kim J, Park K . Polycation gene delivery systems: escape from endosomes to cytosol. J Pharm Pharmacol. 2003; 55(6):721-34. DOI: 10.1211/002235703765951311. View

18.

Elbashir S, Lendeckel W, Tuschl T . RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001; 15(2):188-200. PMC: 312613. DOI: 10.1101/gad.862301. View

19.

Gustavsson J, Parpal S, Karlsson M, Ramsing C, Thorn H, Borg M . Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J. 1999; 13(14):1961-71. View

20.

Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T . Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell. 2006; 10(6):839-50. DOI: 10.1016/j.devcel.2006.04.002. View